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Background: Mapping the intracellular fluxes for established mammalian cell lines becomes increasingly important
for scientific and economic reasons. However, this is being hampered by the high complexity of metabolic
networks, particularly concerning compartmentation.
Results: Intracellular fluxes of the CHO-K1 cell line central carbon metabolism were successfully determined for a
complex network using non-stationary 13C metabolic flux analysis. Mass isotopomers of extracellular metabolites
were determined using [U-13C6] glucose as labeled substrate. Metabolic compartmentation and extracellular
transport reversibility proved essential to successfully reproduce the dynamics of the labeling patterns. Alanine
and pyruvate reversibility changed dynamically even if their net production fluxes remained constant. Cataplerotic
fluxes of cytosolic phosphoenolpyruvate carboxykinase and mitochondrial malic enzyme and pyruvate carboxylase
were successfully determined. Glycolytic pyruvate channeling to lactate was modeled by including a separate pyruvate
pool. In the exponential growth phase, alanine, glycine and glutamate were excreted, and glutamine, aspartate,
asparagine and serine were taken up; however, all these amino acids except asparagine were exchanged reversibly
with the media. High fluxes were determined in the pentose phosphate pathway and the TCA cycle. The latter was
fueled mainly by glucose but also by amino acid catabolism.
Conclusions: The CHO-K1 central metabolism in controlled batch culture proves to be robust. It has the main
purpose to ensure fast growth on a mixture of substrates and also to mitigate oxidative stress. It achieves this by
using compartmentation to control NADPH and NADH availability and by simultaneous synthesis and catabolism
of amino acids.
Keywords: Chinese hamster ovary cells, Metabolic flux analysis, Mitochondria, Compartmentation, Mammalian
metabolism, CHO, Mammalian cell culture, Metabolic transport, ReversibilityBackground
Economic importance and ease of cultivation make
CHO cells a desirable candidate for metabolic studies
in eukaryotic systems. Alongside with being the most
important mammalian cell line for producing biopharma-
ceuticals [1-3], CHO cells are able to grow in suspension
cultures using chemically defined media [4], use multiple* Correspondence: e.heinzle@mx.uni-saarland.de
1Universität des Saarlandes Technische Biochemie, Campus A 1.5, Saarbrücken
D-66123, Germany
Full list of author information is available at the end of the article
© 2014 Nicolae et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.carbon sources simultaneously and maintain a stable
metabolism for long periods in batch cultivations. This
has led to a wealth of studies aimed at exploring CHO
metabolism. After the decoding of the CHO-K1 cell line
genome [5,6] and transcriptome [7], we can expect such
studies to increase both in number and complexity.
Metabolic flux analysis has been applied for mammalian
cells for a long time already but mostly only using metab-
olite balancing [8]. The labelling of extracellular excreted
lactate and CO2 has already been used in the past but only
at metabolic steady state [8-11]. The use of other labelledLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of the often high reversible exchange with the media
[8]. Metabolic flux analysis (MFA) of CHO cell cultures
evolved from flux balancing analysis [12] to more com-
plex metabolic or isotopomer dynamic models [13].
Newer studies rely on 13C-MFA applied by fitting the
summed fractional labeling [14] or by fitting steady-state
labeling data [15] resulted from using in parallel more
labeled substrates for determining the intracellular fluxes
at metabolic steady state in different growth phases. How-
ever, the labeling patterns of the intracellular metabolites
or of amino acids from hydrolyzed proteins that are
usually needed for non-stationary 13C-MFA are obtained
through a tedious methodology [16,17] and are susceptible
to errors stemming mostly from the quenching/extraction
phase [18,19]. In the absence of metabolite exchange with
the media, intracellular labeling would reach steady state
relatively fast, in the order of minutes for glycolytic inter-
mediates and few hours for TCA cycle metabolites, as it
was determined in Pichia pastoris [20]. In mammalian
cells, exchange with the extracellular pools [21] delays the
intracellular isotopic steady state usually beyond the possi-
bility to maintain metabolic steady state. Due to the large
extracellular pools of amino acids, their exchange will
transfer the time constant of the extracellular labeling
process, which is in the order of days, to the intracellular
labeling. One option is to use isotopic non-stationary
metabolic flux analysis (Inst-13CMFA) applied at short
time scales [22], but this approach has the drawback of
requiring accurate determination of intracellular concen-
trations of metabolites [23].
Metabolite and reaction compartmentation is important
for a realistic representation of the mammalian cell
metabolism, but determining it is more challenging both
concerning experimental and modeling procedures, as we
have already reviewed in [24]. In the exponential growth
phase, a typical culture of CHO is characterized by high
uptake rates of glucose and glutamine, the Warburg effect
and the exchange of non-essential amino acids with the
extracellular media [4,25]. We can expect that by feeding
a 13C labeled substrate, some of the extracellular me-
tabolites will exhibit labeling patterns that can then be
detected using GC-MS. As these metabolites will be
enriched in 13C dynamically, non-stationary 13C metabolic
flux analysis (Inst-13CMFA) applied to extracellular and
intracellular isotopomers [26-28] provides a suitable
framework to determine the intracellular fluxes. Extra-
cellular pools have a large time scale for labeling (hours)
compared to the intracellular pools (seconds/minutes),
thus removing the need to sample intracellular pools
provided that the labeling information in the extracellular
metabolites is sufficient.
We show that by using only the labeling patterns of
extracellular metabolites produced by feeding [U-13C6]glucose as the only labeled substrate, intracellular fluxes
can be successfully determined in a complex, compart-
mented metabolic network of the CHO-K1 cell line. In
parallel, we prove that a simplified, non-compartmented
model is not sufficient for describing the metabolism.
We also underline the importance of considering reversibil-
ity when dealing with non-stationary isotopomer models.
Methods
Cell culture and experimental set-up
The CHO-K1 cell line was kindly provided by the Institute
of Cell Culture Technology (University Bielefeld, AG Noll,
Germany). The cells were growing in suspension under
serum and protein free conditions in the chemically de-
fined medium TC-42 (TeutoCell AG, Bielefeld, Germany)
supplemented with 4 mM L-glutamine (PAA, Germany).
Precultures were cultivated in 125 mL baffled Erlenmeyer
flasks (Corning Inc., Germany) at an initial cell density of
0.4×106 cells/mL and a working volume of 50 mL on a
shaking device (225 rpm) at 37°C and 5% CO2 in a humid
atmosphere. For the main cultivation, cells were harvested
during the exponential growth phase at a viability of ≥ 98%
and resuspended in TC-42 medium with 100% [U-13C6]
glucose (99%, Euriso-Top, Saarbrücken, Germany). The
main cultivation was performed in a Vario1000 bioreactor
(Medorex e.K., Nörten-Hardenberg, Germany) at batch
mode with a starting culture volume of 200 mL. The
bioreactor was inoculated at a cell density of 0.4×106
cells/mL. The cultivation temperature was kept constant
at 37°C and the impeller (3-blade marine propeller) speed
was set to 300 rpm. During the cultivation, the pH value
was controlled at 7.2 by gassing with CO2 and by using
0.5 M sodium carbonate solution. Dissolved oxygen was
maintained at 30% of the saturation concentration. Sam-
ples were taken three times a day. Cell density and viabil-
ity were determined by cell counting using the Trypan
blue exclusion method. Supernatants were transferred into
fresh tubes and stored at −20°C until further analysis. The
average cell diameter was determined using an automated
cell counter (Invitrogen, Darmstadt, Germany) in a separ-
ate experiment. This experiment was performed in a shak-
ing incubator (2 inches orbit, 185 rpm, 37°C, 5% CO2
supply) using 250 mL baffled Erlenmeyer flasks (Corning
Inc., Germany), an initial cell density of 0.4×106 cells/mL,
a working volume of 100 mL and using the same TC-42
medium (TeutoCell, Bielefeld, Germany) supplemented
with 4 mM glutamine. Differences of cell diameters during
the cultivation were maximum 5% and not taken into
account. Cell volume was computed assuming the cells are
spherical using a diameter of 10.6 μm. Glutamine deg-
radation kinetics were determined experimentally in a
cell-free setup identical to the one employed for cell vol-
ume estimation. The determined glutamine degradation
rate constant was kdGLN = 0.0033 h
−1.
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Quantification of glucose, organic acids and amino acids
via HPLC was carried out as described previously by
Strigun et al. [29].
Analysis of isotopomer labeling patterns
Sample preparation
For determination of labeling patterns of lactate and amino
acids, 50 μl of supernatants were lyophilized, resolved in
50 μl N,N-dimethylformamide (0.1% pyridine) and incu-
bated at 80°C for 30 min. 50 μl N-methyl-N-t-butyldi-
methylsilyl-trifluoro-acetamide (MBDSTFA) was added
followed by another incubation at 80°C for 30 min for
derivatization of metabolites into corresponding dimethyl-
t-butylsilyl derivatives. For determination of the labeling
pattern of pyruvate, lyophilized supernatants were resolved
in 50 μl pyridine containing 20 mg/ml methoxyamine
hydrochloride and 50 μl MSTFA (Macherey-Nagel, Düren,
Deutschland) and incubated at 80°C for 30 min for deriva-
tization into the methoxyamine-trimethylsilyl derivative.
Derivatized samples were centrifuged at 13000 × g for
5 min at 4°C and supernatants transferred into fresh
glass vials with micro inlets.
GC-MS measurements
Extracellular 13C-labeling dynamics were analyzed by gas
chromatography mass spectrometry (GC-MS). The GC-MS
measurements were carried out on a GC (HP 6890, Hewlett
Packard, Paolo Alto, CA, USA) equipped with an HP5MS
capillary column (5% phenyl-methyl-siloxane diphenylpoly-
siloxane, 30 m× 0.25 mm× 0.25 μm, Agilent Technologies,
Waldbronn, Germany), electron impact ionization at 70 eV,
and a quadrupole detector (Agilent Technologies). The
injection volume was 1 μl (7683B Autosampler, Agilent,
Waldbronn, Germany; PTV-Injektor, Gerstel, Mühlheim
a. d. Ruhr, Germany). Helium was used as carrier gas at
a flow rate of 1.1 ml/min for analysis of lactate and
amino acids or 0.7 ml/min for pyruvate analysis. The
following temperature gradient was applied for lactate
and amino acid analysis: 135°C for 7 min, 10°C/min up
to 162°C, 7°C/min up to 170°C, 10°C/min up to 325°C,
325°C for 2.5 min; inlet temperature: 140°C and heating
with 720°C/min up to 320°C; interface temperature 320°C;
quadrupole temperature 150°C. The temperature gradient
for pyruvate analysis was as follows: 70°C for 1 min,
1°C/min up to 75°C, 5°C/min up to 315°C, 25°C/min up
to 340°C, 340°C for 5 min; inlet temperature: 70°C
and heating with 360°C/min up to 360°C; interface
temperature 320°C; quadrupole temperature 280°C.
Data analysis
After identification of metabolites in the scan mode using
the NIST data bank, quantification of labeling enrichment
was done in SIM (single ion monitoring) mode in twotechnical replicates using the following unique fragments
(m/z) containing the complete carbon skeleton of metabo-
lites: pyruvate 174, lactate 261, alanine 260, glycine 246,
serine 390, aspartate 418, glutamate 432, glutamine
431. Mass isotopomer distributions were corrected for
naturally occurring isotopes using the method of Yang
et al. [30].
Metabolic network models
Two metabolic networks were established based on ex-
perimental observations related to metabolite uptake and
production and extracellular labeling. Both networks
included: glycolysis; TCA cycle; anaplerotic reactions;
synthesis of fatty acids, proteins and carbohydrates for
biomass production; amino acid production and deg-
radation. Transport from the extracellular media was
reversible in both models for all metabolites with the
exception of glucose, asparagine and essential amino acids.
Mitochondrial transport of malate, α-ketoglutarate, alanine,
and reactions of transaminase, malate and lactate de-
hydrogenase were also reversible. The first model shown
in Figure 1A considers the intracellular space without
compartmentation. In the second model (Figure 1B),
the mitochondrial reactions and pools are separated
from the cytosol. Both models start from the annotation
of the genomes of CHO-K1 and Mus musculus [31-33].
Enzyme localization was established using information
from the MGI database and data from J. Wahrheit [34]
who measured compartmented enzyme activity using a
method adapted from Niklas et al. [35]. Mitochondrial
transport of alanine was included to explain the existence
of alanine aminotransferases in both compartments. Me-
tabolite pools were lumped where it did not influence the
simulated labeling dynamics. Pentose phosphate pathway
was reduced to one reaction where one carbon atom is
lost for each G6P molecule and 5/3 molecules of PG are
produced. Glycolysis was lumped to three fluxes trans-
forming G6P into PYRcyt. Isocitrate and citrate were con-
densed into one citrate (CIT) pool. Succinate, fumarate
and malate were condensed into one MAL pool. Two
cytosolic pyruvate pools were used to describe metabolic
channeling to lactate. Non-essential amino acids catabol-
ism was lumped to three fluxes fueling the MAL, AcoA
and GLU pool respectively. No carbon mapping was re-
quired in this case as essential amino acids are unlabeled.
Glutaminase activity was mitochondrial [5] and glutamine
synthetase was cytosolic [36]. Fatty acids, protein and stor-
age carbohydrates composition of the cell was taken from
Altamirano et al. [12].
In total, the compartmented model consisted of 60
fluxes and 25 metabolites and the non-compartmented
model of 42 fluxes and 16 metabolites. The complete
flux list for the two models, together with the carbon
transfer rules, is provided in the Additional file 1.
Figure 1 Non-compratmented (A) and compartmented (B) networks of the CHO-K1 central metabolism used for simulations.
Irreversibility is indicated by simple arrows, and reversibility by double arrows. The reactions depicted in 1B are listed in detail in the Additional
file 1 together with fluxes and reversibilities determined. Subscripts meaning: ex – extracellular; c – cytosolic; m – mitochondrial. Abbreviations:
AA –amino acids; AcoA – acetyl CoA; AKG – alpha-ketoglutarate; ALA – alanine; ASN – asparagine; ASP – aspartate; CIT/ICI – citrate/isocitrate;
G6P – glucose 6-phosphate; GLC – glucose; GLN – glutamine; GLU – glutamate; GLY – glycine; MAL – malate; OAA – oxaloacetate; PEP –
phosphoenolpyruvate; PG – phosphoglycerate; PYR – pyruvate; SER – serine.
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Isotopic non-stationary metabolic flux analysis (Inst-13CMFA)
comprises: (1) metabolic steady-state balancing of intra-
cellular metabolites for determining extracellular rates;
(2) dynamic extracellular metabolite and isotopomer
balance and (3) dynamic balances of intra-compart-
mental isotopomers.
Metabolite balancing
Net extracellular rates vM_ex were determined for each
extracellular metabolite M_ex for the batch cultivation
situation, under the assumption of metabolic steady
state, by fitting the cell density X(t) and extracellular
concentrations of metabolites CM_ex to an exponential
growth model with specific growth rate μ (eq. 1.a and
eq. 1.b) and constant extracellular rates. Glutamine
balance included first order degradation in the culture
media (eq. 1.c).
dX=dt ¼ μX tð Þ ð1:aÞ
dCM ex=dt ¼ vM exX tð Þ ð1:bÞdCGLN=dt ¼ vGLN ⋅X tð Þ−kdGLN ⋅CGLN tð Þ ð1:cÞ
At intracellular metabolic steady state, the n metabolic
fluxes that connect the m metabolites are constant and
satisfy the material balance:
G⋅v ¼ 0 ð2:aÞ
vj ¼ φj; j ¼ 1::Rmeas ð2:bÞ
αi ≤ vi ≤ βi; i¼1 ::n ð2:cÞ
where G is the m × n stoichiometric matrix and its null
space v is the vector of net metabolic fluxes which are
constrained by Rmeas measured fluxes φj (2.b) and n
inequalities (2.c) determined by flux direction. To reduce
the number of parameters, the free fluxes were extracted
from the network as described in [37] to produce a de-
termined stoichiometric system.
Intracellular and extracellular carbon balance
The Inst- 13CMFA framework developed in [23,28] was
adapted to the case of batch culture cultivation. Isotopo-
mer balances for extracellular (eq. 3) and intracellular
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with IDVM_ex, IDVM_cyt, IDVM_in, being the isotopomer
distribution vectors of the extracellular, cytosolic and
intracompartmental pools of metabolite M. IDVM_in,j is
the jth reaction contribution to isotopomers of metabol-
ite M, computed using isotopomer mapping matrices as
described by Schmidt [28]. Xconc is the cell volumetric
concentration expressed in L cell/L media. CM_ex is the
extracellular concentration of M, vinMex is the production
flux of M expressed in mmol/(L cell × h), voutMex is the
uptake flux, vj is one of the RM fluxes entering the
intracompartmental pool of M, CM_in, and voutMin is the
flux exiting the pool. The metabolite and isotopomer
balances from equations 1,2 and 4 are then solved sim-
ultaneously to obtain the time course of the mass iso-
topomer distributions. Isotopomer balancing employs
absolute fluxes that can be computed from the net
fluxes by introducing a reversibility parameter:
revj ¼ vj;reversevj ð5Þ
where vj is the net flux and vj, forward and vj, reverse are the
forward and respectively the reverse exchange fluxes,
with vj, forward – vj,reverse = vj; vj, forward ≥0 and vj,reverse ≥0.
The contribution of reaction j was computed using
isotopomer mapping matrices [28] that trace carbon
from the substrate to the reaction products. The initial
mass distribution of all metabolites was computed consid-
ering the naturally occurring 13C fraction (1.1%) and the
99% atom purity of the employed 13C labeled substrate.
The simulated time course of extracellular mass iso-
topomer distributions (MID) is compared with the experi-
mental values. The objective function to be minimized was
expressed as the weighted sum of square differences be-
tween the experimentally determined and simulated MIDs:





where SSQD is the objective function, MIDsim is the
simulated MID, MIDexp is the measured MID and ΣMIDis the measurement covariance matrix. The optimal solu-
tion was accepted if it satisfied the χ-squared test for
model verification with 95% probability, and N-p degrees
of freedom, where N is the number of sampled points (size
of MIDexp) and p is the number of free parameters. To
reduce the bias in the objective function generated by very
small standard deviations, a minimum threshold of 0.005
was imposed. Accurate confidence intervals and sensitivity
analysis of fluxes were computed according to [38]. All
the code was programmed and simulated in Matlab
[MATLAB and Simulink Release 2013a, The MathWorks,
Inc., Natick, Massachusetts, United States].
Results and discussion
Metabolic profiling
The cells exhibited exponential growth for 72 h (Figure 2)
until glutamine became exhausted and a shift in metabol-
ism was observed (data not shown). Estimated specific
growth rate as fitted to eq. (1.a) was μ = 0.0401 h−1. Up-
take and production of most metabolites was balanced, i.e.
they were proportional to growth for the main carbon
sources and produced metabolites (Figure 2) and for other
amino acids (Additional file 2).This means that metabolic
steady state was maintained during the first 72 h of cul-
tivation. Glucose constituted the main carbon source
(Table 1), providing 65% of the total carbon entering the
central carbon metabolism, with an uptake flux of
371 mmol/(L cell × h). Note that all fluxes are related to
the cell volume specified by L cell. 39% of the glucose was
converted to lactate. The observed pyruvate production
rate was 3.3 mmol/(L cell × h).
The glutamine uptake flux determined by fitting eq.
(1.c) to the glutamine concentration over time was
66.4 mmol/(L cell × h), 16% smaller than that in the
case when its degradation was ignored. Glutamine uptake
contributed with 10% to the total carbon pool. The rest of
the carbon feeding the central carbon metabolism, i.e.
25%, was obtained from amino acids catabolism.
Alanine, glycine and glutamate were produced (Figure 3),
while the other amino acids were taken up in excess of the
quantity required for biomass synthesis. As a consequence
of amino acids catabolism, a flux of 92.6 mmol/(L cell × h)
fueled the mitochondrial acetyl-CoA pool from the
degradation of isoleucine, leucine, lysine, phenylalan-
ine and tyrosine, while a flux of 39.1 mmol/(L cell × h)
cytosolic AcoA was directed towards fatty acids syn-
thesis. The catabolism of excess isoleucine, methio-
nine, phenylalanine, threonine, tyrosine and valine that
remained after protein synthesis produced 49.6 mmol/
(L cell × h) succinate and fumarate (lumped into one
pool of four carbon di-carboxylic acids, here represented
as MAL).
Metabolite dilution by growth was neglected due to
negligible influence on the total mass balance.
Figure 2 Culture profile of the CHO-K1 cells for the first 72 h
during the exponential growth phase. Experimental values are
shown with circles and calculated values are represented by
solid lines.
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The MID of extracellular pyruvate, lactate, alanine,
glutamate, glutamine, aspartate, serine and glycine was
sampled at 1, 18, 24, 42, 48, 66 and 72 h. During the
exponential growth phase of 72 h none of the labeling
reached steady state as shown in Figure 4. Lactate and
pyruvate exhibited similar labeling dynamics, however
with different MIDs towards the end of the growth.
This is surprising since lactate is obtained from pyru-
vate through the lactate dehydrogenase reaction. The
predominant lactate fraction, i.e. M + 3, increased to
0.85 and the pyruvate M + 3 fraction stabilized at 0.81,pointing towards glycolytic channeling to lactate achieved
by the localized cooperation of glycolytic enzymes as
observed in rapidly proliferating cells [39,40]. From the
produced amino acids, alanine, also derived from pyruvate,
had a high M+ 3 fraction. Glutamate and glycine M+ 2
fractions increased slowly, with most of the change happen-
ing in the last 24 h due to the high number of producing
cells present in the media., Extracellular aspartate, glutam-
ine and serine were found to be labeled although they ex-
hibited a net uptake. Glutamine fractional labeling, mostly
the M+ 2 isotopomer, increased sharply at the end of the
phase, when very little glutamine remained in the media
and the contribution of secreted glutamine played a large
role to the labeling state.Isotopomer fitting
Both the non-compartmented and compartmented isoto-
pomer network models (Figure 1) were fitted to the experi-
mental mass distributions with the goal of determining
unknown fluxes and reversibilities. The 7 sampling time
points of the 8 metabolites produced a total number of 252
experimentalMIDs.
Convergence to the optimal solution is difficult in
isotopomer models [41] and the parameter space of the
objective function is marked by a multitude of local
minima [42], making gradient-based algorithms unreliable.
Consequently, we applied a global optimization scheme
that had the following steps: (1) generate an initial random
population of (40 x p) parameter sets that satisfy con-
straints using a simulated annealing-based algorithm, (2)
submit the population to a 50-generations genetic algo-
rithm optimization, and (3) refine the best solution using
a trust region reflective algorithm. Convergence to the
optimal solution was verified by repeating the optimization
scheme. One simulation took about 3 s, and the
optimization procedure required about 40 h on a 2.3 GHz
QuadCore CPU. All the numerical integration and
optimization algorithms are found in Matlab toolboxes.
We had initial difficulties in fitting pyruvate and ala-
nine labeling dynamics. As it was shown that re-
versibility greatly affects labeling dynamics [43], we
assumed that the transport reversibility parameter
changes in time, even if the net fluxes remain constant.
The decrease with time of pyruvate transport reversibility




timeþε , where pyruvate transport reversibility
revPYR decreases from a starting value rev0PYR . To avoid
division by zero, a negligible correction factor ε was intro-
duced. Alanine transport into the cell intensifies as extra-
cellular alanine becomes exponentially more abundant.
Transport reversibility was expressed in this case as
revALA = α ⋅ exp(β ⋅ time), where α and β are parameters to
be determined.





[mmol/(L cell × h)]
Uptake flux
[Cmmol/(L cell × h)]
Percentage of the
total carbon-flux
Glucose Pyruvate 371.0 2226.2 64.9
Glutamine AKG 66.4 331.9 9.7
AA1* AcoA 92.6 185.2 5.4
AA2* Malate 49.6 198.4 5.8
AA3* AKG 11.6 58.2 1.7
ASP/ASN OAA 68.1 272.3 7.9
Serine Pyruvate, glycine 48.3 146.4 4.3
TOTAL - - 3428.53 100
The contribution of AA1, AA2 and AA3 amino acid groups considers only catabolism. Abbreviations: AA1: amino acids catabolized to AcoA (isoleucine, leucine,
lysine, phenylalanine, tyrosine); AA2: amino acids catabolized to four-carbon dicarboxylic acids (isoleucine, methionine, phenylalanine, threonine, tyrosine, valine);
AA3: amino acids catabolized to glutamate (arginine, histidine, proline); AcoA: acetyl coenzyme A; AKG: alpha-ketoglutarate; ASN: asparagine; ASP: aspartate;
OAA: oxaloacetate.
*Excluding requirements for protein synthesis.
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model (Figure 1A) consisted of 5 fluxes, 18 reversibilities
and the CO2 pool. At convergence, the model failed to
fit the data with the minimized SSQD of 1572, larger
than χ2 (0.95, 252–24) = 264.2. Pyruvate, lactate, alanine
and glutamate labeling were fit poorly even when trans-
port reversibility was variable (Figure 4). In consequence,
the non-compartmented model was rejected. The low la-
beling content of pyruvate, alanine and lactate simulated
with the non-compartmented model is explained by the
lumping of the cytosolic and mitochondrial pyruvate
pools. As more than 30% of the carbon feeding the TCA
cycle is not labeled, it is expected that the cataplerotic
reactions catalyzed by phosphoenolpyruvate carboxyki-
nase and malic enzyme will produce a large quantity of
unlabeled pyruvate, which contradicts the experimental
observations.
The compartmented model, consisting of 11 free fluxes
and other 27 free parameters (reversibilities) depicted in
Figure 1B, fitted the data successfully with the minimized
SSQD = 249.0 slightly smaller than χ2 (0.95, 252–38) =
249.13. The complete experimental and simulated data-
sets, together with the standard deviation of the measured
mass isotopomer distributions, are listed in Additional file
3. The poorer fit of the 66 and 72 h time points for lactate
and 72 h for alanine can be explained by the metabolic
shift towards the end of the growth phase. From a param-
eter fitting point of view, exponential growth will add a
larger contribution in the objective function to the label-
ing towards the end of the exponential phase compared to
the beginning of the experiment because the rates of 13C
accumulation in the extracellular media will be much
larger at high cell densities. This is best evidenced in
Figure 4 where glutamine, aspartate, serine and glycine
do not become noticeably labeled until 40 h after the
introduction of the labeled substrate.Metabolic fluxes in the CHO-K1 cell line
Glucose was converted to PG mostly by bypassing glycoly-
sis (Figure 5) through the pentose phosphate pathway
(PPP). The estimated PPP flux was 80% of the total molar
glucose input flux, a high activity contrasting with results
obtained by Ahn and Antoniewicz for adherently growing
CHO cells [14] but observed for hybridoma [44] and
cancer cells [45]. A wide range of PPP activities, between
0–160% of the glucose input flux, was determined for a
highly-productive CHO line in fed-batch cultivation con-
ditions at different growth phases [15]. The large quan-
tities of cytosolic NADPH produced through PPP are used
to drive fatty acids synthesis and possibly to mitigate oxi-
dative stress by reducing reactive oxygen species [46-50],
as it has also been proposed by [15]. Overflow to lactate
comprised 39% of the pyruvate produced from glycolysis.
From the rest of the cytosolic pyruvate, 42.7 mmol/(L
cell × h) were converted to alanine, but most of it was
transported into the mitochondria and converted to
AcoA. The channeling flux from PEP to lactate was
122.7 mmol/(L cell × h), accounting for 42% of the total
lactate being produced. Low reversibility (Figure 5) meant
no connection between the two cytosolic pyruvate pools
PYRc1 and PYRc2 existed. However, lactate was produced
from both cytosolic pyruvate pools, indicating that glyco-
lytic channeling is not the only lactate source in the cell.
Our possible explanation is that multi-enzyme complexes
associated to membrane transporters, as characterized by
Campanella et el. [51], create a micro-compartmented
environment in the cytosol. Glycolytic enzymes are partly
associated and partly soluble, resulting in a mixed response
in the lactate labeling.
The carbon flux in the TCA cycle originated mainly
from AcoA produced from glycolytic pyruvate transported
into the mitochondria (Figure 5), with significant contribu-
tions from glutamine and essential amino acids catabolism.
Figure 3 Compartmentation of the CHO-K1 metabolism and the fate of extracellular metabolites. Net fluxes are indicated on the gray
arrows in units of mmol product/ (L cell × h), and reversibility parameter defined as reverse flux/net flux is shown in the square brackets (n.d. = not
determined). The thickness of the gray arrows is proportional to the forward flux (=reverse flux + net flux), and shown qualitatively for the fluxes with
variable reversibility. Net flux direction is shown by the black arrow heads. Amino acids catabolism is represented as the sum of the differences
between amino acid uptake flux and flux required for protein production, reported to the metabolite derived from catabolism. Subscripts meaning:
ex – extracellular; c – cytosolic; m – mitochondrial. Abbreviations: AAex1 – isoleucine, leucine, lysine, phenylalanine, tyrosine catabolized to acetyl-CoA;
AAex2 - isoleucine, methionine, phenylalanine, threonine, tyrosine, valine catabolized to fumarate and succinate; AAex3 – arginine, histidine, proline
catabolized to glutamate; AcoA – acetyl CoA; ALA – alanine; ASN – asparagine; ASP – aspartate; CIT/ICI – citrate/isocitrate; GLN – glutamine;
GLU – glutamate; GLY – glycine; MAL – malate; PYR – pyruvate; SER – serine.
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http://www.biomedcentral.com/1752-0509/8/50Such a high activity of the TCA cycle and high connectivity
with the glycolysis is in contrast with some previous re-
ports of lower activity during exponential growth phase
[14,52,53] but similar to [54-56]. The differences can be
assigned mainly to the use of different cell lines and culti-
vation conditions like media composition, aeration mode,
pH control and culture type e.g. suspension or immobi-
lized, batch or fed-batch. The lower lactate/glucose molar
ratio of 0.78 reported herein means more pyruvate is
available for use in the TCA cycle, thus making for a
more efficient metabolism. Gluconeogenesis was active
through PEP carboxykinase with 10% of the total flux
entering the PEP pool, a fact explained qualitatively by the
presence of M + 2 lactate and pyruvate. In the absence ofgluconeogenesis, only the M and M+ 3 mass isotopomers
of these metabolites would be present after feeding fully
labeled glucose. Malic enzyme activity was negligible in
the cytosol, and this is in agreement with compartmented
enzyme activity observed by J. Wahrheit [34]. This obser-
vation reaffirms that PPP was the main source of cytosolic
NADPH. Mitochondrial malic enzyme was highly active,
producing one third of the total mitochondrial pyruvate.
However, a part of the mitochondrial pyruvate was
recycled back into the TCA cycle via pyruvate carboxylase.
Mitochondrial malate net transport flux was small and
reversible. This explained the lack of M + 1 labeling in lac-
tate, alanine and pyruvate that would have been otherwise
linked to the M + 2 malate isotopomers that are expected
Figure 4 Non-stationary 13C labeling experiment. Experimental mass isotopomer distributions (symbols) with their standard deviations vs.
simulated (line) mass isotopomer distributions of labeled extracellular metabolites. The plots A-C represent results from using the non-compartmented
metabolic network specified in Figure 1A. For the other eight plots (D-K), the compartmented model provided in Figure 1B was simulated.
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http://www.biomedcentral.com/1752-0509/8/50to be obtained in the TCA cycle. As a consequence, the
M+ 2 labeling in these metabolites relies on mitochon-
drial transport of citrate and on the activity of citrate lyase
producing cytosolic AcoA and OAA, which is then further
converted to PEP.
About one third of the total serine was produced from
PG, using cytosolic glutamate for transamination. Serine
was exchanged with the media, thus explaining extracel-
lular labeling of serine. Half of the serine was not used
for protein synthesis but was reversibly converted to
glycine and C1 units to sustain the high anabolic
activity. Glycine was then secreted. The remaining
excess of serine was converted to pyruvate. Alanine wassynthesized mainly from cytosolic pyruvate in a highly
reversible reaction. Connectivity between cytosolic and
mitochondrial alanine pools and the direction of the
mitochondrial alanine aminotransferase flux could not
be determined. However, the transport flux of alanine
to/from mitochondria was confined between −11.6 to
13.6 mmol/(L cell × h), i.e. ±25% of the alanine produc-
tion flux. The flux of 68.1 mmol/(L cell × h) from as-
paragine and aspartate uptake to oxaloacetate was split
through aspartate aminotransferases between cytosolic
and mitochondrial oxaloacetate with a 3/1 ratio, but no
other details could be inferred due to the low labeling
level in extracellular aspartate.
Figure 5 Estimated net intracellular fluxes in the CHO-K1 central metabolism. Qualitatively shown by the arrow thickness and their 95%
confidence intervals (number interval) together with reversibility confidence intervals (square brackets). n.d. – not determined.
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http://www.biomedcentral.com/1752-0509/8/50Isocitrate dehydrogenase (IDH) activity in the cytosol
could not be reliably determined due to lack of informa-
tion in directly connected metabolites citrate and AKG,
but also because it affects the labeling pattern in the
same way as the mitochondrial isozyme. As a result, the
flux in the CITm-CITc-AKGc-AKGm cycle could not be
determined. Nevertheless, a net activity of cytosolic GDH
towards producing the high glutamate flux needed forcytosolic transamination reactions implies that AKG is
either produced in the cytosol by IDH or transported from
the mitochondria into the cytosol. Mitochondrial glutam-
ate pool was fed by transporting cytosolic glutamate into
the mitochondria and by glutamine through GLS activity
at comparable rates. In the mitochondria, glutamate was
then converted to AKG and fed into the TCA cycle
through mitochondrial GDH. In the cytosol, the glutamate
Nicolae et al. BMC Systems Biology 2014, 8:50 Page 11 of 15
http://www.biomedcentral.com/1752-0509/8/50produced from AKG in the various transaminase reactions
was partially converted to glutamine, which was then ex-
changed with the media, leading to the presence of labeled
glutamine in the media. In conclusion, simultaneous
degradation and synthesis pathways for glutamine involve
glutamine uptake, transport into the mitochondria and
conversion to glutamate, glutamate dehydrogenation to
AKG, AKG transport to the cytosol or citrate transport
and citrate conversion to AKG through cytosolic IDH
activity, conversion of AKG to cytosolic glutamate, and
cytosolic glutamine synthesis.Transport reversibility
A very important part in modeling the extracellular
labeling was considering the reversible exchange between
the intracellular pools and the extracellular media, a
phenomenon which affects the dynamics of the label-
ing process. All sampled extracellular non-essential
amino acids except asparagine and proline, either pro-
duced or taken up, were exchanged with the culture
media (Figure 3). Even if the production flux of alanine
remained constant throughout the cultivation, the fitting
remained poor for alanine when considering a constant
reversibility factor. There, the reversibility was estimated
to increase with time. The function revALA = 0.154 ⋅ exp
(0.0359 ⋅ time) was used to compute the forward and re-
verse exchange fluxes (eq. 5), with both parameters being
determined with a narrow confidence interval (Additional
file 1). Time is computed in hours. This successfully
explained the dynamics of alanine labeling. The time con-
stant of the reversibility function is a value close to the
specific growth rate, pointing to the fact that alanine re-
uptake is correlated to the extracellular concentration.
Serine secretion flux, as computed with eq. 5, was up to
35 times higher than the net uptake flux. Glycine re-
uptake flux was 4.6 times the net production flux. Aspar-
tate, glutamate and glutamine exchange fluxes were in the
same order with the net uptake/production flux, as
expressed by the estimated reversibility parameter values
of about 1. The confidence intervals for the transport
reversibility parameters are larger than those for fluxes
because at high reversibilities the labeling becomes less
sensitive to small changes in reversibility.
Pyruvate transport reversibility is described by the func-
tion revPYR ¼ 2700timeþ0:01, where time is specified in hours. The
hyperbolic function implies that at the beginning of the cul-
tivation, the intense exchange of pyruvate [57] eliminates
the difference between the labeling of the intracellular and
extracellular pools. Pyruvate re-uptake decreases because
pyruvate concentrations changes slightly (Figure 1) while
lactate accumulates in the media to reach high concen-
trations and competes with pyruvate for the monocar-
boxylate transporters [58,59]. Lactate transport reversibilityparameter could not be estimated because at the beginning
of the cultivation there is no lactate present in the
media that could dilute the intracellular pool and affect
the labeling dynamics.
Confidence intervals calculation and sensitivity analysis
Most of the fluxes depicted in Figure 5 were determined
with narrow confidence intervals. Interval boundaries
are not symmetrical due to the non-linear characteristics
of the mathematical model. Determining both the flux
and exchange in alternative pathways was not possible in
the case of high reversibility e.g. for determining the com-
partmentation of alanine metabolism involving reversible
transaminase reactions.
The sensitivity coefficients provided quantitative infor-
mation about the impact of the measured fluxes on the
estimated flux values (Figure 6A). Sensitivity analysis
also evidenced correlations between external fluxes and
network pathways when [U-13C6] glucose is used. In this
case, the MIDs of metabolites will depend on the inter-
play between the multitude of non-labeled carbon
sources and the glucose feed, as opposed to organisms
that use only one carbon source [60]. The determination
of anaplerotic fluxes relied on the supply of four carbon
metabolites from amino acids catabolism. Changes in
the glutamine uptake flux (Figure 6A) affected most
fluxes to a large extent. Nevertheless, the high influence
was mainly computational, as any increase of the flux
caused depletion of glutamine at the end of the cultiva-
tion and dramatically different labeling patterns. Glucose
uptake flux affected the estimation of the PPP and TCA
cycle fluxes. Errors in measuring glucose concentration
over time will propagate in the values of these fluxes, as
the glucose uptake flux determines the fraction of 13C
entering the cell. G6P loses one 13C through oxPPP,
therefore estimating the split between glycolysis and
oxPPP depends highly on determining correctly all carbon
sources. This explains the high sensitivity of the glycoly-
sis/oxPPP split to all extracellular fluxes. Unexpected cor-
relations were observed for the glycine production flux
that influenced most anaplerotic and aminotransferase
fluxes. Glycine is produced at the expense of serine, which
is in turn produced from 3-phosphoglycerate, also con-
verting glutamate to alpha-ketoglutarate during trans-
amination, and simultaneously converted to pyruvate,
thus affecting the availability of both cytosolic pyruvate
and glutamate.
Local sensitivity of the SSQD to free parameters com-
puted as the normalized mean deviation of the objective
function to variations in the estimated parameters shown
in Figure 6B evidenced the determinable parameters and
the redundant parameters. Notoriously difficult to deter-
mine anaplerotic fluxes PEP carboxykinase and mitochon-
drial malic enzyme induced a noticeable sensitivity in the
Figure 6 Sensitivity analysis to measured fluxes and to parameters. The sensitivity represented in the heat map (A) was computed for the
compartmented network of CHO-K1 when [U-13C6] glucose was used as a labeled substrate, Sensvevm ¼ ðdve=ve Þ=ðdvm=vmÞ, where Sensvevm is the sensitivity
of the estimated flux ve, re-estimated using values of the measured flux vm at the border of the confidence interval. vm
* is the average measured flux.
The bar chart below (B) shows the normalized sensitivity of the objective function (SensSSQD) to the free parameters (fluxes and rev = reversibilities).
The sensitivity was obtained as a mean value of 100 perturbations of each parameter around the estimated value: SensSSQD ¼ ðdSSQD=SSQDÞ=ðdpi=pi Þ,
where SSQD* is the optimized value of the objective function (eq. 6), and pi* is the estimated value of parameter i. The rates vi correspond to the rates in the
network shown in Figure 1A. Abbreviations: subscripts: c: cytosolic, ex: extracellular, m: mitochondrial; ALA: alanine; AcoA: acetyl coenzyme
A; AKG: alpha-ketoglutarate; ASN: asparagine; ASP: aspartate; CIT: citrate; G6P: glucose 6-phosphate; GLC: glucose; GLN: glutamine; GLU:
glutamate; GLY: glycine; LAC: lactate; MAL: malate; OAA: oxaloacetate; PEP: phosphoenolpyruvate; PG: phosphoglycerate; PYR: pyruvate;
SER: serine.
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http://www.biomedcentral.com/1752-0509/8/50objective function. The increased network connectivity,
obtained by coupling ALA or ASP deamination to conver-
sion of AKG to GLU, contributed to this fact. Oppositely,
most intracellular reversibilities did not influence the par-
ameter estimation results. This can be easily inferred from
the fact that while reaction reversibility affects the dynam-
ics of intracellular isotopomers, it does not mirror in the
extracellular labeling apart from the reactions altering thecarbon backbone. Also, in the situation where high values
of the reversibilities resulted from estimation, local pertur-
bations around these values will not influence the MIDs.
Conclusions
We have shown that intracellular fluxes of the CHO-K1
cell line central carbon metabolism in batch culture can be
determined for a complex network by making use solely of
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http://www.biomedcentral.com/1752-0509/8/50the mass isotopomers of extracellular metabolites resulted
from feeding [U-13C6] glucose as the only labeled substrate.
To this end, non-stationary 13C metabolic flux analysis
proved an effective tool for unraveling important details of
the CHO-K1 metabolism. Pathway compartmentation, e.g.
of anaplerotic reactions and amino acid metabolism had
to be considered for describing the mass isotopomer dis-
tribution. We reckon that this fact plays an essential role
in controlling the availability of NADH and NADPH in
mitochondria and cytosol, but also in facilitating amino
acid catabolism. A cancer-like high activity of the pentose
phosphate pathway produced reducing NADPH partly
to counteract the oxidative stress generated by the
mitochondrial respiration and partly to fuel fatty acids
biosynthesis. Cytosolic pyruvate transport is reversible
thousand-fold compared to the net production flux,
indicating that although it is not a carbon source, pyru-
vate creates an extracellular environment [61] most
probably by functioning as a balancing system for cyto-
solic NADH [62]. Considering that metabolite exchange
with the media played a very important role in determin-
ing the intracellular fluxes, we expect that future 13CMFA
studies of mammalian cells metabolism will include this
essential aspect. Compartmentation controls the simultan-
eous degradation and production of non-essential amino
acids. Most likely, the CHO-K1 cells maintain the expo-
nential growth phase under batch conditions by using a
well-connected multi-pool system involving metabolite
and reaction compartmentation, exchange with the media
and inter-compartment exchange for controlling the me-
tabolite and cofactor pools. Further studies on localizing
enzyme and transporter activity together with sampling
intra-compartmental concentrations would bring valuable
contributions at elucidating the function of such cycling
pathways. Accurate enzyme kinetics and thermodynamics
[63] in mammalian cells would complement the modeling
using Inst-13CMFA with information about reaction dir-
ection and reversibility. The knowledge gained through
Inst-13CMFA depicts the CHO-K1 central metabolism
as a robust, highly interconnected network that ensures
fast growth and mitigates stress generated by reactive
oxygen species and the accumulation of lactate in the
culture media.
Due to the economic importance of CHO cells, efficient
production processes leading to high product quality with
minimum effort are of utmost importance. In-depth
knowledge about CHO metabolism is expected to provide
valuable assistance in identifying targets for metabolic
engineering and guiding the design of feeding strategies
leading to the development of efficient production pro-
cesses. Overexpression, silencing or knockout of the spe-
cific glycolytic enzymes that associate with channeling
glucose to lactate could either be used to study the control
of the Warburg effect in cancer cells or for improvingglucose utilization. Because glutamine is a limiting sub-
strate, overexpressing glutamine synthetase would enable
cells to run a more efficient energy metabolism, with
higher fluxes in the TCA cycle. However, as we have
shown that compartmentation is important in managing
metabolites, mitochondrial transporters are likely to
constitute important targets for genetic modifications.
Inter-compartmental transport of metabolites is a key
factor in connecting the cytosol and the mitochondria
energetically and we reckon that modifying the genetic
expression of transporters will have significant, perhaps
surprising effects on the overall metabolism.
Our proposed methodology of sampling the MID only
in extracellular metabolites for determining intracellular
fluxes using Inst-13CMFA has the potential of broader
applications, as it circumvents the need to extract intra-
cellular metabolites and it is non-invasive to cells. The
information contained in the extracellular mass isotopo-
mers has a higher resolution compared to the summed
fractional labeling used previously in [14]. This is suffi-
cient for resolving a complex metabolic network when
more metabolites are produced and/or exchanged with
the culture media. Therefore, we foresee future applications
in the study of mammalian metabolism at physiological and
pathological conditions, especially related to compartmen-
tation, as reviewed in [64], and oxidative stress, e.g. in can-
cer, neurodegenerative disorders and ageing. Knowledge
about the metabolism at the compartment level will be
essential for identifying therapeutic targets and under-
standing disease mechanisms. Similarly, the method
could be applied to other enzymatic systems or pro-
karyotic cells where an extended metabolite exchange
with the media occurs.
Additional files
Additional file 1: List of reactions in the non-compartmented
central carbon metabolism of CHO-K1 (Table S1). List of metabolic
reactions, fluxes and reversibilities in the compartmented central carbon
metabolism of CHO-K1 (Table S2). Carbon transfer rules are provided in
the parentheses after each reaction. Reversible reactions are designated
by double arrows. Reversibility is computed as the ratio between the
reverse flux and the net flux.
Additional file 2: Complete culture profile of CHO-K1 during the
exponential growth phase.The lines represent the fitted concentration
profiles to the experimental values (dots) and in the boxes are the
determined extracellular rates [mmol/(L cell × h )] together with the 95%
confidence intervals. Glutamine uptake was determined by considering a
spontaneous degradation rate of 0.0033 h−1. The exponential growth
phase is shown in the last plot.
Additional file 3: Experimental and simulated mass isotopomer
distributions of extracellular metabolites and used standard
deviations.
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